Kenya has vowed to continue supporting HIV/AIDS patients despite the U.S. cutting foreign aid. The Trump administration’s decision to halt funding has sparked concerns over access to lifesaving antiretroviral drugs (ARVs).
Medical Services PS Harry Kimtai assured patients that Kenya has enough ARVs to sustain treatment for over 1.4 million people. He stated that the government would reallocate funds to ensure continued support. Treasury is expected to step in to fill the funding gap.
Kimtai made the remarks in Naivasha after a meeting with the Kenya Bureau of Standards (KEBS). He emphasized that malaria and tuberculosis programs would also receive financial backing despite the aid freeze.
The government is also planning healthcare reforms. Kimtai revealed that a Quality of Care Bill would soon be introduced. The bill aims to improve healthcare services in both public and private hospitals.
KEBS Managing Director Esther Ngari said a new healthcare management system is in place. The system will enhance efficiency and ensure better service delivery in health facilities.
The aid freeze has disrupted key programs under USAID, CDC, and PEPFAR. These agencies were instrumental in providing ARVs and reducing infections in Kenya and other African nations. With funding now cut, governments are racing to secure alternative resources.
The suspension of U.S. support could have devastating effects. Millions across Africa depend on these programs for HIV treatment. Global health organizations have warned of severe consequences if immediate action is not taken.
Kenya remains committed to protecting those affected. Leaders are working on sustainable solutions to keep critical health programs running.
By Newsmedia